Osteoporosis

Latest News

Assessing the BMD-Fracture Risk Relationship: A Meta-Regression Analysis

By

Tyler Rice

A meta-regression analysis indicated that greater improvements in BMD were strongly associated with greater reductions in fracture risk, especially in the vertebrae and hip.

Assessing Risk for Invasive Oral Events in Women Treated With Denosumab

By

Brandon May

Despite the relatively high prevalence of invasive oral events in women treated with denosumab, rates of osteonecrosis of the jaw remain low and tend to resolve with further therapy.

Vertebral Fracture Assessment Imaging May Predict Incident Fractures

By

Caleb Rans

Researchers examined the associations of prevalent vertebral fracture identified on vertebral fracture assessment images in routine practice with incident fractures.

Probiotics, Mucus Supplements Prevent Postantibiotic Bone Loss

By

Endocrinology Advisor Contributing Writer

Supplementation with probiotic Lactobacillus reuteri and mucus supplements significantly prevent bone loss from consequences of postantibiotic microbial gut dysbiosis.

BMD Improved Significantly With Denosumab vs Bisphosphonates in Osteoporosis

By

Gary Rothbard MD, MS

Results from a meta-analysis show that denosumab improved bone mineral density significantly more than bisphosphonates at the lumbar spine, total hip, and femoral neck.

Niacin Intake May Be Linked to Hip Fracture Risk in Older Adults

By

Roxanne Nelson, BSN, RN

Both high and low niacin intake was associated with a risk for incident hip fractures in older adults.

Serum Estradiol Levels Predictive of Fractures During Menopausal Transition

By

Tyler Rice

Measuring serum estradiol during the menopausal transition might help identify women at higher risk for fractures.

Vitamin D, Calcium May Improve BMD in Postmenopausal Women With RA, Osteoporosis

By

Caleb Rans

Bone mineral density measures were significantly greater at 3 years in postmenopausal women with comorbid osteoporosis and rheumatoid arthritis who were given vitamin D and calcium supplementation.

FDA Panel Votes on Novel Osteoporosis Treatment Evenity

By

Diana Ernst, RPh

In the Biologics License Application (BLA) resubmission, Amgen and UCB proposed to narrow the indication to treatment of osteoporosis in postmenopausal women at high risk of fracture.

Primary Hypertension May Not Affect Prognosis of Postmenopausal Osteoporosis

By

Sheila Jacobs

The presence of primary hypertension does not appear to have an effect on the prognosis of postmenopausal osteoporosis.

Gender-Affirming Hormonal Treatment and Long-Term Bone Safety

By

Tyler Rice

Gender-affirming hormonal treatment does not negatively affect bone mineral density in transgender people.